Arrigoni Sara C, IJsselhof Rinske, Postmus Douwe, Vonk Judith M, François Katrien, Bové Thierry, Hazekamp Mark G, Rijnberg Friso M, Meyns Bart, van Puyvelde Joeri, Poncelet Alain J, de Beco Geoffroy, van de Woestijne Pieter C, Bogers Ad J J C, Schoof Paul H, Ebels Tjark
Department of Cardiothoracic Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Pediatric Cardiac Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
J Thorac Cardiovasc Surg. 2022 Mar;163(3):1166-1175. doi: 10.1016/j.jtcvs.2021.05.015. Epub 2021 May 18.
The study objective was to analyze survival and incidence of Fontan completion of patients with single-ventricle and concomitant unbalanced atrioventricular septal defect.
Data from 4 Dutch and 3 Belgian institutional databases were retrospectively collected. A total of 151 patients with single-ventricle atrioventricular septal defect were selected; 36 patients underwent an atrioventricular valve procedure (valve surgery group). End points were survival, incidence of Fontan completion, and freedom from atrioventricular valve reoperation.
Median follow-up was 13.4 years. Cumulative survival was 71.2%, 70%, and 68.5% at 10, 15, and 20 years, respectively. An atrioventricular valve procedure was not a risk factor for mortality. Patients with moderate-severe or severe atrioventricular valve regurgitation at echocardiographic follow-up had a significantly worse 15-year survival (58.3%) compared with patients with no or mild regurgitation (89.2%) and patients with moderate regurgitation (88.6%) (P = .033). Cumulative incidence of Fontan completion was 56.5%, 71%, and 77.6% at 5, 10, and 15 years, respectively. An atrioventricular valve procedure was not associated with the incidence of Fontan completion. In the valve surgery group, freedom from atrioventricular valve reoperation was 85.7% at 1 year and 52.6% at 5 years.
The long-term survival and incidence of Fontan completion in our study were better than previously described for patients with single-ventricle atrioventricular septal defect. A concomitant atrioventricular valve procedure did not increase the mortality rate or decrease the incidence of Fontan completion, whereas patients with moderate-severe or severe valve regurgitation at follow-up had a worse survival. Therefore, in patients with single-ventricle atrioventricular septal defect when atrioventricular valve regurgitation exceeds a moderate degree, the atrioventricular valve should be repaired.
本研究旨在分析单心室合并不平衡型房室间隔缺损患者的生存率及Fontan手术完成率。
回顾性收集来自4个荷兰和3个比利时机构数据库的数据。共选取151名单心室房室间隔缺损患者;36例患者接受了房室瓣手术(瓣膜手术组)。观察终点为生存率、Fontan手术完成率以及免于房室瓣再次手术。
中位随访时间为13.4年。10年、15年和20年的累积生存率分别为71.2%、70%和68.5%。房室瓣手术并非死亡的危险因素。超声心动图随访时存在中重度或重度房室瓣反流的患者,其15年生存率(58.3%)显著低于无或轻度反流患者(89.2%)以及中度反流患者(88.6%)(P = 0.033)。Fontan手术完成率在5年、10年和15年时分别为56.5%、71%和77.6%。房室瓣手术与Fontan手术完成率无关。在瓣膜手术组中,1年时免于房室瓣再次手术的比例为85.7%,5年时为52.6%。
我们研究中Fontan手术完成患者的长期生存率优于先前报道的单心室房室间隔缺损患者。同期进行的房室瓣手术并未增加死亡率或降低Fontan手术完成率,而随访时存在中重度或重度瓣膜反流的患者生存率较差。因此,对于单心室房室间隔缺损且房室瓣反流超过中度的患者,应修复房室瓣。